NEW STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORMS

Abstract

A stability indicating, accurate, specific, linear and sensitive reverse phase-HPLC method was developed and validated for the determination of Rosuvastatin calcium (ROS) in pharmaceutical dosage form. The chromatographic separation was performed using Eclipse XDB plus C18 Column (4.6 × 150 mm, 5μm particle size). Mobile phase was made by using Acetonitrile: Water (60:40 v/v) at a flow rate of 1.0 ml/min with the detection wavelength at 242 nm. The retention time of ROS was found to be about 1.787 min. The linearity was obtained in the concentration range of 10-50 μg/ml with a correlation coefficient of 0.999. The percentage purity of ROS was found to be 100.06 %. The percentage recovery was determined for ROS and found to be 100.53 %. The developed analytical method was validated for linearity, precision, accuracy, ruggedness, robustness, specificity and system suitability which were within the acceptance limit according to ICH guidelines. All the degradation products obtained by stress conditions were found to be well separated from the principal peak, which means that the ROS peaks were highly pure in all chromatograms obtained. The developed method was found to be applicable for routine quality control and stability analysis of ROS in pharmaceutical dosage forms.

Authors and Affiliations

Usha Rani N, Nagoor Ankani

Keywords

Related Articles

ANTIOXIDANT ACTIVITIES OF INCLUSION COMPLEXES OF 2-(BENZOTHIAZOLYL-2’) HYDRAZONO-3-PHENYL 5-ARYLIDENE- 4- THIAZOLIDINONE DERIVATIVES WITH Β-CYCLODEXTRIN

The present study focused on the preparation and antioxidant studies of inclusion complexes of some compounds of 4-Thiazolidinone derivatives with β-cyclodextrin. The inclusion complex has been prepared in order to incre...

IN-VITRO EVALUATION AND MOLECULAR DOCKING STUDIES OF SOME SCHIFF BASES AS CHOLINESTERASE INHIBITOR

Some new Schiff bases of 4-aminopyridine were synthesized and evaluated for antiamnesic and cognition enhancing activity. In the current study to further understand the mechanism of action of these derivatives we have ev...

DEVELOPMENT AND VALIDATION OF ISOCRATIC STABILITY INDICATING REVERSE PHASE LC METHOD WITH PDA DETECTION FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE IN ITS MARKETED FORMULATION

A simple and precise stability indicating RP-HPLC method was developed and validated for simultaneous determination of Olmesartan Medoxomil (OLM) and Hydrochlorothiazide (HCTZ) in pure drug and Pharmaceutical marketed fo...

HUTCHINSON-GILFORD PROGERIA SYNDROME: A PREMATURELY AGING DISORDER

Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare genetic disorder characterized by premature aging, involving aberrant splicing of the LMNA gene, resulting in the production of a disease-causing mutant la...

INFLUENCE OF FORMULATION COMPONENTS ON AEROSOLIZATION PROPERTIES OF ISONIAZID LOADED CHITOSAN MICROSPHERES

The objective of the present study was to prepare microspheres with small size and good sphericity by spray drying technology using Isoniazid (INH) as model drug, chitosan as encapsulating polymer; lactose and L Leucine...

Download PDF file
  • EP ID EP624999
  • DOI -
  • Views 85
  • Downloads 0

How To Cite

Usha Rani N, Nagoor Ankani (2014). NEW STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORMS. International Journal of Pharmaceutical Sciences and Drug Research, 6(4), 283-290. https://europub.co.uk/articles/-A-624999